| Dr Babak Marefat, MD | |
|
823 Sw Mulvane St, Topeka, KS 66606-1764 | |
| (785) 354-9591 | |
| Not Available |
| Full Name | Dr Babak Marefat |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 25 Years |
| Location | 823 Sw Mulvane St, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417902297 | NPI | - | NPPES |
| 067284 | Other | KS | MEDICARE PTAN |
| 100458310A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 04-30085 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Stormont Vail Hospital | Topeka, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cotton O'neil Clinic Revocable Trust | 5496659195 | 576 |
News Archive
Researchers at Yale University School of Medicine found that SARS-CoV-2 viral loads in saliva are higher for patients with associated risk factors and underlying conditions that lead to severe COVID-19 and death. Thus, saliva viral loads could be used to predict disease severity.
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.
Integrated multi-agency work will be needed to address the poor physical and mental health experienced by street-based sex workers (SSWs), according to recent research including a new study by Bristol University.
In a surprising outcome that overturns the conventional wisdom on the body's immune response to infection, scientists at The Scripps Research Institute have shown that T cells do not begin proliferation until up to three days after infection.
A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.
› Verified 9 days ago
| Entity Name | Cotton O'neil Clinic Revocable Trust |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944457 PECOS PAC ID: 5496659195 Enrollment ID: O20031124000674 |
News Archive
Researchers at Yale University School of Medicine found that SARS-CoV-2 viral loads in saliva are higher for patients with associated risk factors and underlying conditions that lead to severe COVID-19 and death. Thus, saliva viral loads could be used to predict disease severity.
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.
Integrated multi-agency work will be needed to address the poor physical and mental health experienced by street-based sex workers (SSWs), according to recent research including a new study by Bristol University.
In a surprising outcome that overturns the conventional wisdom on the body's immune response to infection, scientists at The Scripps Research Institute have shown that T cells do not begin proliferation until up to three days after infection.
A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Babak Marefat, MD 823 Sw Mulvane St, Topeka, KS 66606-1764 Ph: (785) 354-9591 | Dr Babak Marefat, MD 823 Sw Mulvane St, Topeka, KS 66606-1764 Ph: (785) 354-9591 |
News Archive
Researchers at Yale University School of Medicine found that SARS-CoV-2 viral loads in saliva are higher for patients with associated risk factors and underlying conditions that lead to severe COVID-19 and death. Thus, saliva viral loads could be used to predict disease severity.
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.
Integrated multi-agency work will be needed to address the poor physical and mental health experienced by street-based sex workers (SSWs), according to recent research including a new study by Bristol University.
In a surprising outcome that overturns the conventional wisdom on the body's immune response to infection, scientists at The Scripps Research Institute have shown that T cells do not begin proliferation until up to three days after infection.
A team of Vanderbilt researchers have demonstrated for the first time that a new type of gene therapy, called RNA interference, can heal a genetic disorder in a live animal.
› Verified 9 days ago
Trent L. Vande Garde, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 619 Sw Corporate View, Topeka, KS 66615 Phone: 785-235-3322 Fax: 785-235-1217 | |
Walter Dan Weaver, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 619 Sw Corporate View, Topeka, KS 66615 Phone: 785-235-3322 Fax: 785-246-6258 | |
Rita R. Tablante, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 619 Sw Corporate View, Topeka, KS 66615 Phone: 785-235-3322 Fax: 785-246-6258 | |
Thomas J Ashley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1616 Sw 8th Ave, Topeka, KS 66606 Phone: 785-233-2280 Fax: 785-233-6918 | |
Randall J Kresie, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 6001 Sw 6th Ave, Suite 210, Topeka, KS 66615 Phone: 785-233-0011 Fax: 785-233-1292 | |
Dr. Gray W Woods, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-5613 Fax: 785-354-6426 |